O S Levin Selected Research

Tremor (Tremors)

1/2015	[Pramipexole in Parkinson's disease].
1/2011	[Dysport in the treatment of essential tremor].
1/2010	[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease].
1/2009	[Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O S Levin Research Topics

Disease

30	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2003
16	Dementia (Dementias) 01/2023 - 01/2005
14	Cognitive Dysfunction 01/2023 - 01/2006
7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
6	Pain (Aches) 01/2021 - 01/2009
5	Dyskinesias (Dyskinesia) 01/2022 - 01/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2013
5	Stroke (Strokes) 01/2020 - 01/2013
4	Mental Disorders (Mental Disorder) 01/2018 - 01/2015
4	Brain Diseases (Brain Disorder) 01/2018 - 01/2005
4	Tremor (Tremors) 01/2015 - 01/2009
3	Ischemic Stroke 01/2020 - 01/2013
3	Mood Disorders (Mood Disorder) 01/2019 - 01/2010
2	Brain Ischemia (Cerebral Ischemia) 01/2023 - 01/2014
2	Tardive Dyskinesia 01/2022 - 01/2015
2	Multiple System Atrophy 01/2020 - 01/2014
2	Lewy Body Disease (Lewy Body Dementia) 01/2020 - 07/2009
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2014 - 01/2010
2	Radiculopathy (Radiculopathy, Cervical) 01/2009 - 01/2009
1	Bilateral Vestibulopathy 01/2023
1	Tics (Tic) 01/2022
1	Restless Legs Syndrome (Restless Legs) 01/2022
1	Psychomotor Agitation (Akathisia) 01/2022
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2021
1	COVID-19 01/2021
1	Osteoarthritis 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Corticobasal Degeneration 01/2020
1	Speech Disorders (Cluttering) 01/2020
1	Conduct Disorder (Conduct Disorders) 01/2020
1	Tauopathies 01/2020
1	Craniocerebral Trauma (Head Injury) 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020
1	Herpes Zoster Oticus (Geniculate Neuralgia) 01/2020
1	Aphasia (Dysphasia) 01/2020
1	Low Back Pain (Lumbago) 01/2019
1	Orthostatic Hypotension (Postural Hypotension) 01/2018
1	Disease Progression 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Autoimmune Diseases of the Nervous System 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Syncope (Fainting) 01/2016
1	Amyloid Plaque 01/2016
1	Brain Injuries (Brain Injury) 01/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015
1	Ataxia (Dyssynergia) 01/2015
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2015
1	Synucleinopathies 01/2014
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2014

Drug/Important Bio-Agent (IBA)

13	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2003
10	Memantine (Namenda)FDA Link 01/2023 - 01/2008
5	cerebrolysinIBA 01/2023 - 01/2019
4	MelatoninIBA 01/2023 - 01/2013
4	Monoamine Oxidase (MAO)IBA 01/2019 - 01/2008
4	rasagiline (Azilect)FDA Link 01/2017 - 01/2008
4	StalevoIBA 01/2013 - 01/2006
3	Antidepressive Agents (Antidepressants)IBA 01/2019 - 01/2016
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 01/2009
3	Galantamine (Galanthamine)FDA LinkGeneric 01/2018 - 01/2005
3	Pramipexole (Mirapex)FDA LinkGeneric 01/2015 - 01/2009
2	Donepezil (Aricept)FDA LinkGeneric 01/2020 - 01/2018
2	AntibodiesIBA 01/2017 - 01/2012
2	Carbidopa (Lodosyn)FDA LinkGeneric 01/2017 - 01/2006
2	N-Methylaspartate (NMDA)IBA 01/2017 - 01/2013
2	Piracetam (Nootropil)IBA 10/2010 - 01/2007
2	tianeptine (Stablon)IBA 05/2007 - 01/2006
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2018
1	EnzymesIBA 01/2018
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2018
1	entacapone (Comtan)FDA Link 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2015
1	Coffee FDA Link 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015
1	Buspirone (Buspar)FDA LinkGeneric 01/2015
1	LipidsIBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2014
1	Warfarin (Coumadin)FDA LinkGeneric 01/2014

Therapy/Procedure

21	Therapeutics 01/2023 - 01/2006
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Cognitive Training 01/2023 - 01/2020
2	Transcranial Magnetic Stimulation 01/2019 - 01/2016
2	Aftercare (After-Treatment) 01/2013 - 01/2012
1	Palliative Care (Palliative Therapy) 01/2020
1	Activities of Daily Living (ADL) 01/2016
1	Magnetic Field Therapy 01/2016
1	Thrombolytic Therapy 01/2014